Yao Wu

670 total citations
29 papers, 526 citations indexed

About

Yao Wu is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Yao Wu has authored 29 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Cancer Research. Recurrent topics in Yao Wu's work include Berberine and alkaloids research (4 papers), Plant-based Medicinal Research (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yao Wu is often cited by papers focused on Berberine and alkaloids research (4 papers), Plant-based Medicinal Research (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yao Wu collaborates with scholars based in China, United States and Thailand. Yao Wu's co-authors include Li Sun, Hongzhi Du, Shengtao Yuan, Ligong Lu, Meixiao Zhan, Ji Li, Bin He, Yu Nie, Zhongwei Gu and Li Li and has published in prestigious journals such as Oncogene, Frontiers in Immunology and RSC Advances.

In The Last Decade

Yao Wu

28 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yao Wu China 14 299 99 82 64 64 29 526
Rishi K. Gara India 12 323 1.1× 84 0.8× 57 0.7× 35 0.5× 98 1.5× 12 594
Chunjie Wen China 15 316 1.1× 162 1.6× 60 0.7× 48 0.8× 105 1.6× 29 519
Yufan Gu China 15 291 1.0× 65 0.7× 76 0.9× 60 0.9× 64 1.0× 31 623
Dipita Bhakta-Guha India 10 376 1.3× 109 1.1× 65 0.8× 62 1.0× 209 3.3× 18 761
Xiwei Ji China 9 229 0.8× 77 0.8× 64 0.8× 48 0.8× 129 2.0× 21 459
Yang Ke China 12 314 1.1× 108 1.1× 53 0.6× 53 0.8× 86 1.3× 29 616
Marta Hałas‐Wiśniewska Poland 11 231 0.8× 60 0.6× 75 0.9× 37 0.6× 76 1.2× 32 466
Song Yi Bae South Korea 17 337 1.1× 86 0.9× 104 1.3× 36 0.6× 122 1.9× 29 632
Yang Ke China 14 250 0.8× 126 1.3× 72 0.9× 54 0.8× 75 1.2× 34 617
Binqiang Tian China 11 268 0.9× 91 0.9× 73 0.9× 43 0.7× 70 1.1× 14 497

Countries citing papers authored by Yao Wu

Since Specialization
Citations

This map shows the geographic impact of Yao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao Wu more than expected).

Fields of papers citing papers by Yao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao Wu. The network helps show where Yao Wu may publish in the future.

Co-authorship network of co-authors of Yao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yao Wu. A scholar is included among the top collaborators of Yao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao Wu. Yao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zheng, Yao Wu, Gang Li, et al.. (2025). Discovery of HMPL-306 (Ranosidenib), a New Potent and Selective Dual Inhibitor of Mutant IDH1 and 2 in Clinical Development for Cancer Treatment. ACS Medicinal Chemistry Letters. 16(3). 454–463. 2 indexed citations
2.
3.
Wang, Xuemei, et al.. (2023). The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy. Frontiers in Immunology. 14. 1202633–1202633. 8 indexed citations
4.
Li, Hongchao, et al.. (2023). Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis. Frontiers in Pharmacology. 14. 1156081–1156081. 8 indexed citations
5.
6.
Wu, Yao, Hongzhi Du, Meixiao Zhan, et al.. (2020). Sepiapterin reductase promotes hepatocellular carcinoma progression via FoxO3a/Bim signaling in a nonenzymatic manner. Cell Death and Disease. 11(4). 248–248. 26 indexed citations
7.
Wu, Yao, Hongzhi Du, Zhibo Zhang, et al.. (2019). I-8, a novel inhibitor of mutant IDH1, inhibits cancer progression in vitro and in vivo. European Journal of Pharmaceutical Sciences. 140. 105072–105072. 8 indexed citations
8.
Quan, Xingping, Hongzhi Du, Jingjing Xu, et al.. (2019). Novel Quinoline Compound Derivatives of NSC23925 as Potent Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance. Frontiers in Chemistry. 7. 820–820. 9 indexed citations
9.
Hou, Xiaoying, Hongzhi Du, Xingping Quan, et al.. (2018). Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway. Frontiers in Pharmacology. 9. 21–21. 43 indexed citations
10.
Du, Hongzhi, Yulong Chen, Xiaoying Hou, et al.. (2017). PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC. Cell Death and Disease. 8(10). e3143–e3143. 73 indexed citations
11.
Ma, Xiaoyuan, Yao Wu, Xuewei Yang, et al.. (2016). A Novel 1,2-Dihydroquinoline Anticancer Agent and Its Delivery to Tumor Cells Using Cationic Liposomes.. PubMed. 36(5). 2105–11. 8 indexed citations
12.
13.
Liu, Ruijuan, Lu Zheng, Yao Wu, et al.. (2016). Simultaneous determination of corynoline and acetylcorynoline in human urine by LC–MS/MS and its application to a urinary excretion study. Journal of Chromatography B. 1014. 83–89. 8 indexed citations
14.
Wu, Yao, Yanyong Xu, Li Ma, et al.. (2015). PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice. Journal of Translational Medicine. 13(1). 316–316. 18 indexed citations
15.
Gu, Shuang, Xiaochun Yang, Xiyan Xiang, et al.. (2015). Sanguinarine-induced apoptosis in lung adenocarcinoma cells is dependent on reactive oxygen species production and endoplasmic reticulum stress. Oncology Reports. 34(2). 913–919. 30 indexed citations
16.
Liu, Ruijuan, Yao Wu, Lu Zheng, et al.. (2015). LC–MS/MS determination and urinary excretion study of seven alkaloids in healthy Chinese volunteers after oral administration of Shuanghua Baihe tablets. Journal of Pharmaceutical and Biomedical Analysis. 118. 89–95. 21 indexed citations
17.
Liu, Ruijuan, Lei Wang, Yao Wu, et al.. (2015). Study on the pharmacokinetic profiles of corynoline and its potential interaction in traditional Chinese medicine formula Shuanghua Baihe tablets in rats by LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 117. 247–254. 21 indexed citations
18.
Wu, Yao, et al.. (2014). Associations between the rs6010620 Polymorphism in RTEL1 and Risk of Glioma: a Meta-analysis of 20,711 Participants. Asian Pacific Journal of Cancer Prevention. 15(17). 7163–7167. 8 indexed citations
19.
Yin, Taiqi, et al.. (2014). Phosphorylation of Dok1 by Abl family kinases inhibits CrkI transforming activity. Oncogene. 34(20). 2650–2659. 7 indexed citations
20.
Nie, Yu, Ji Li, Hong Ding, et al.. (2012). Cholesterol Derivatives Based Charged Liposomes for Doxorubicin Delivery: Preparation, In Vitro and In Vivo Characterization. Theranostics. 2(11). 1092–1103. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rishi K. Gara Breakdown of academic impact, for papers by Chunjie Wen Breakdown of academic impact, for papers by Yufan Gu Breakdown of academic impact, for papers by Dipita Bhakta-Guha Breakdown of academic impact, for papers by Xiwei Ji Breakdown of academic impact, for papers by Yang Ke Breakdown of academic impact, for papers by Marta Hałas‐Wiśniewska Breakdown of academic impact, for papers by Song Yi Bae Breakdown of academic impact, for papers by Yang Ke Breakdown of academic impact, for papers by Binqiang Tian
Rankless by CCL
2026